prostate

Mark Cuban pharmacy could save billions on prostate cancer, bladder drugs

Vanderbilt research found that a new drug company founded by entrepreneur Mark Cuban could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on just the nine most popular urological drugs.

VISE team seeks to develop new robot to ease prostatectomies

The Vanderbilt Institute for Surgery and Engineering (VISE) team of Robert Webster III, PhD, and Duke Herrell, MD, have received a $2.2 million grant from the National Institutes of Health to develop a new surgical robot for endoscopic transurethral prostatectomy.

Sharing the stage

Legendary actor Ed Asner shared the stage with Vanderbilt’s Joseph (Jay) Smith Jr., M.D., at the Franklin Theatre Saturday night after Asner performed his sold-out show “A Man and His Prostate.”